International Journal of STD & AIDS > Volume 20, Number 9 > Pp. 595-600

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Kim, H N Articles by Spach, D H PubMed PubMed Citation Social Bookmarking                      What's this?

Review

Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations

H N Kim MD MSc , R D Harrington MD, H M Crane MD MPH, S Dhanireddy MD, T H Dellit MD and D H Spach MD

Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Harborview Medical Center, Seattle, WA, USA

Correspondence to: Dr H Nina Kim, 325 Ninth Avenue, Box 359930, Seattle, WA 98104, USA Email: hyangkim{at}u.washington.edu

Immunization with hepatitis B (HBV) vaccine is recommended for all HIV-infected individuals without immunity to HBV. This patient population, however, has relatively poor HBV vaccine responses. Factors associated with this impaired HBV vaccine response in HIV-infected individuals may include older age, uncontrolled HIV replication, and low nadir CD4 cell count. Postvaccination testing for HBV surface antibody is recommended and vaccine non-responders should undergo repeat immunization with a full series. The benefit of double dosage, the appropriate strategy for HIV-infected patients with isolated HBV core antibody and the timing and number of vaccinations in persons with advanced immunosuppression on highly active antiretroviral therapy remain controversial areas.

Key Words: HIV • hepatitis B vaccination

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?